Overview |
bsm-60286R |
LYPD3 monoclonal Antibody |
WB, IHC-P, IF, ICC |
Human |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human LYPD3 |
Monoclonal |
C4F10 |
IgG |
1mg/ml |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
27076 |
O95274 |
Cell membrane |
C4.4A; FLJ10525; GPI-anchored metastasis-associated protein C4.4A homolog; GPI-anchored metastasis-associated protein homolog; Ly6/PLAUR domain-containing protein 3; LYPD3_HUMAN; Matrigel-induced gene C4 protein; MIG-C4; SHINC3. |
Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Nov 2021] |
Application Dilution |
WB |
=1:500-1000 |
IHC-P |
IHC-P=1:50-100 |
IF |
ICC=1:50 |
ICC |
IF=1:50-100 |